The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis

NCT03178669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: cobitolimod
DRUG: Placebo

Sponsor

InDex Pharmaceuticals